Table 3 Association between PD-L1 expression in tumor-infiltrating mononuclear cells (TIMCs) and clinico-pathological factorsa
Characteristic | % Positive tumor- infiltrating mononuclear cells | p-value | ||
|---|---|---|---|---|
Score < 5 (low) (n = 27, 57.4%), n | Score ≥ 5 (high) (n = 20, 42.6%), n | Total (n = 47)‚ n | ||
Gender | > 0.999 | |||
Male | 15 | 11 | 26 | |
Female | 12 | 9 | 21 | |
Age | 0.769 | |||
65≥ | 14 | 11 | 25 | |
65< | 13 | 9 | 22 | |
Stage | 0.073 | |||
I + II | 19 | 8 | 27 | |
III + IV | 8 | 12 | 20 | |
Recurrence or metastasis after surgery | 0.011 | |||
No | 19 | 12 | 31 | |
Yes | 8 | 8 | 16 | |
Outcome | 0.049 | |||
Alive | 23 | 12 | 35 | |
Death | 4 | 8 | 12 | |